Vancouver, BC – March 31, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need… Read More
TORONTO, ON (March 31 2020) – The Gairdner Foundation is pleased to announce the 2020 Canada Gairdner Award laureates, recognizing some of the world’s most significant biomedical research and discoveries…. Read More
Vancouver, BC – March 27, 2020 – Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that recent developments have suggested the potential utility of its lead drug… Read More
March 26, 2020 – Vancouver, Canada — Genome BC is today launching a rapid response funding program to invest in promising research and innovation projects with the real potential to… Read More
SAN DIEGO, March 26, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that it… Read More
